Product name:GDC-0941 bismesylate
CAS:957054-30-7
Molecular Formula:C23H27N7O3S2
Formula Weight:705.83 g/mol
Description:GDC-0941 bismesylate is a potent, selective, orally bioavailable inhibitor of PI3K currently being developed by Genentech and being evaluated in human clinical trials for the treatment of cancer.